Articles

Find an Article

Filter articles

Applied Filters

Showing 171 to 180 of 274 results

CJEU clarifies rules on parallel pharma imports

EU, UK02-10-2015

The Court of Justice of the European Union has clarified when pharmaceutical patent owners may rely on the Specific Mechanism to prevent parallel imports of their products.

CJEU clarifies rules on combination SPCs

UK02-10-2015

An Advocate General in the Court of Justice of the European Union, Niilo Jääskinen, has clarified how the regulation for supplementary protection certificates should be interpreted concerning medicinal products made with a combination of active ingredients.

Further unravelling the SPC Gordian Knot

EU01-10-2015Avi Toltzis and Penny Gilbert

The CJEU’s decision in Forsgren has brought greater clarity to the scope of the SPC regulation, including whether a substance is an active ingredient, as Avi Toltzis and Penny Gilbert of Powell Gilbert explain.

SPCs: Questions of validity

Austria, EU01-10-2015Michael Pitzner-Bruun

The tussle between Teva and Amgen over the latter’s SPC for lipegfilgrastim is still playing out in Denmark’s IP court and may yet be referred to the CJEU. Michael Pitzner-Bruun of law firm Kromann Reumert reports.

SPCs: When a few days makes a difference

EU01-10-2015Anja Lunze and Paul England

An advocate-general at Europe’s highest court has said SPCs should come into effect once an applicant for a marketing authorisation has been notified of that authorisation. This is good news for SPC owners, say Anja Lunze and Paul England of Taylor Wessing.

Warner-Lambert v Actavis: lessons from ‘the case of the year’

UK01-10-2015Arty Rajendra

The Warner-Lambert v Actavis case concerning second medical use patents has resulted in a carefully considered judgment and there are some clear lessons to be learnt, says Arty Rajendra of Rouse Legal.

Interpol: clamping down on pharma crime

International01-10-2015Aline Plançon

The international police organisation Interpol plays a vital role in connecting law enforcement and health authorities around the world in the fight against pharmaceutical crime. Aline Plançon reports.

SPCs: When a few days makes a difference

Austria, EU24-09-2015Anja Lunze and Paul England

An advocate-general at Europe’s highest court has said SPCs should come into effect once an applicant for a marketing authorisation has been notified of that authorisation. This is good news for SPC owners, say Anja Lunze and Paul England of Taylor Wessing.

Europe v US: the patentability of diagnostic claims

EU, US17-09-2015Andrew Carridge and Neil Thornton

Researchers should keep in mind that broad claims applying the discovery of a biomarker and disease correlation are currently patentable in Europe but not in the US. Andrew Carridge and Neil Thornton of Reddie & Grose report.

London calling: the benefits of the UPC’s new home

UK10-09-2015Claire Phipps-Jones

Aldgate Tower will make an ideal home for the UK division of the UPC, with many advantages for its likely users, says Claire Phipps-Jones of Bristows.

Showing 171 to 180 of 274 results

LSIPR